Mercury Laboratories Limited (MERCURYLAB.BO)
INR 840.0
(4.87%)
INR 840.0
(4.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 101.18 Million INR | -12.24% |
| 2022 | 102.89 Million INR | 31.82% |
| 2021 | 79.33 Million INR | -23.63% |
| 2020 | 104.7 Million INR | 61.86% |
| 2019 | 70.15 Million INR | 8.0% |
| 2018 | 67.66 Million INR | 28.77% |
| 2017 | 48.37 Million INR | -35.92% |
| 2016 | 70.74 Million INR | 7.28% |
| 2015 | 70.98 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 16.05 Million INR | -42.67% |
| 2023 Q2 | 28.43 Million INR | 57.38% |
| 2023 Q1 | 18.06 Million INR | 22.88% |
| 2023 Q3 | 22.29 Million INR | -21.6% |
| 2023 FY | - INR | -12.24% |
| 2023 Q4 | 26.51 Million INR | 18.93% |
| 2022 FY | - INR | 31.82% |
| 2022 Q1 | 27.59 Million INR | 41.62% |
| 2022 Q4 | 14.7 Million INR | 26.79% |
| 2022 Q3 | 11.59 Million INR | -76.33% |
| 2022 Q2 | 48.99 Million INR | 77.55% |
| 2021 Q1 | 22.82 Million INR | 58.67% |
| 2021 Q2 | 20.2 Million INR | -11.48% |
| 2021 FY | - INR | -23.63% |
| 2021 Q3 | 14.24 Million INR | -29.51% |
| 2021 Q4 | 19.48 Million INR | 36.84% |
| 2020 FY | - INR | 61.86% |
| 2020 Q3 | 36.94 Million INR | 19.69% |
| 2020 Q1 | 19.27 Million INR | 902.63% |
| 2020 Q4 | 14.38 Million INR | -61.07% |
| 2020 Q2 | 30.86 Million INR | 60.15% |
| 2019 Q1 | 21.21 Million INR | 95.24% |
| 2019 FY | - INR | 8.0% |
| 2019 Q4 | 1.92 Million INR | -93.0% |
| 2019 Q3 | 27.46 Million INR | 29.67% |
| 2019 Q2 | 21.18 Million INR | -0.14% |
| 2018 FY | - INR | 28.77% |
| 2018 Q4 | 10.86 Million INR | -45.98% |
| 2018 Q1 | 18.03 Million INR | 66.44% |
| 2018 Q2 | 18.15 Million INR | 0.63% |
| 2018 Q3 | 20.11 Million INR | 10.81% |
| 2017 Q1 | -8.39 Million INR | -149.69% |
| 2017 FY | - INR | -35.92% |
| 2017 Q4 | 10.83 Million INR | -41.85% |
| 2017 Q3 | 18.63 Million INR | -31.73% |
| 2017 Q2 | 27.29 Million INR | 425.03% |
| 2016 Q2 | 20.76 Million INR | 4.82% |
| 2016 Q1 | 19.8 Million INR | 92.76% |
| 2016 FY | - INR | 7.28% |
| 2016 Q3 | 13.27 Million INR | -36.04% |
| 2016 Q4 | 16.9 Million INR | 27.29% |
| 2015 Q1 | 19.27 Million INR | 91.54% |
| 2015 Q2 | 21.58 Million INR | 11.97% |
| 2015 FY | - INR | 0.0% |
| 2015 Q4 | 10.27 Million INR | -51.97% |
| 2015 Q3 | 21.39 Million INR | -0.88% |
| 2014 Q4 | 10.06 Million INR | -37.74% |
| 2014 Q1 | 18.59 Million INR | 0.0% |
| 2014 Q3 | 16.16 Million INR | -23.08% |
| 2014 Q2 | 21.01 Million INR | 12.98% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | -11.61% |
| Bacil Pharma Limited | -569.32 Thousand INR | 17873.484% |
| BDH Industries Limited | 124.27 Million INR | 18.576% |
| Beryl Drugs Limited | 26.63 Million INR | -279.849% |
| Cian Healthcare Limited | 122.56 Million INR | 17.443% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -512.592% |
| Deccan Health Care Limited | 37.5 Million INR | -169.792% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 3820.147% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -22.481% |
| Concord Drugs Limited | 40.52 Million INR | -149.724% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -537.324% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 87.823% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -15741.466% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -751.178% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 73.221% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -773.515% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 83.424% |
| Makers Laboratories Limited | 25.81 Million INR | -292.019% |
| Medi-Caps Limited | 4.77 Million INR | -2020.897% |
| MedPlus Health Services Limited | 3.94 Billion INR | 97.432% |
| Panchsheel Organics Limited | 189.36 Million INR | 46.565% |
| Parmax Pharma Limited | 22.93 Million INR | -341.147% |
| Parnax Lab Limited | 243.59 Million INR | 58.461% |
| Patidar Buildcon Limited | -5.52 Million INR | 1931.126% |
| Phaarmasia Limited | -1.58 Million INR | 6496.207% |
| PRAVEG LIMITED | 321.43 Million INR | 68.52% |
| Sunil Healthcare Limited | 93.07 Million INR | -8.712% |
| Syschem (India) Limited | 70.4 Million INR | -43.731% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -15.534% |
| Sastasundar Ventures Limited | -203.51 Million INR | 149.721% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 25023.153% |
| Smruthi Organics Limited | 120.31 Million INR | 15.895% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -125.846% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 60.189% |
| Trident Lifeline Limited | 102.69 Million INR | 1.466% |
| Transchem Limited | 56.61 Million INR | -78.743% |
| Trinity League India Limited | -26.25 Million INR | 485.434% |
| Tyche Industries Limited | 128.2 Million INR | 21.075% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 73.848% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 412.511% |
| Vivanza Biosciences Limited | 11.2 Million INR | -803.142% |
| Zenith Healthcare Limited | 4.98 Million INR | -1928.629% |
| Zenlabs Ethica Limited | 27.09 Million INR | -273.443% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -13.682% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -20.139% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 166.988% |
| Roopa Industries Limited | 55.7 Million INR | -81.663% |
| PANJON LTD. | 4.08 Million INR | -2374.639% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 182.078% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 631.115% |
| Anuh Pharma Limited | 878.5 Million INR | 88.482% |
| Crestchem Limited | 30.33 Million INR | -233.576% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 1035.367% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -272.11% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 73.986% |
| Trimurthi Limited | -2.47 Million INR | 4182.614% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 53.282% |
| Norris Medicines Limited | -1.78 Million INR | 5771.512% |
| Veerhealth Care Limited | 15.99 Million INR | -532.623% |
| Lactose (India) Limited | 201.22 Million INR | 49.713% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 205.217% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 40.677% |
| Gennex Laboratories Limited | 219.35 Million INR | 53.871% |
| Denis Chem Lab Limited | 224.84 Million INR | 54.997% |
| Colinz Laboratories Limited | 5.42 Million INR | -1764.186% |
| Godavari Drugs Limited | 134.62 Million INR | 24.837% |
| Zenotech Laboratories Limited | 172.64 Million INR | 41.39% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 77.452% |
| Bharat Parenterals Limited | 265.74 Million INR | 61.922% |
| Coral Laboratories Limited | 227.07 Million INR | 55.439% |
| Evoq Remedies Limited | 6.18 Million INR | -1535.236% |
| Kerala Ayurveda Limited | 70.78 Million INR | -42.947% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 1280.31% |
| Natural Capsules Limited | 219.9 Million INR | 53.985% |
| Auro Laboratories Limited | 121.73 Million INR | 16.879% |